- Breast
- Lung
- Gastrointestinal
- Genitourinary
- Gynecologic Oncology
- Leukemia
- Lymphoma
- Myeloma
- Hematologic Malignancies
- Head and Neck
- General Oncology
- Palliative Care
- Events
ASH 2023 Insights: "Mosunetuzumab + Polatuzumab Vedotin in Pts With R/R LBCL"
By
Insights from 2023 ASH Annual Meeting
FEATURING
Elizabeth Budde
By
Insights from 2023 ASH Annual Meeting
FEATURING
Elizabeth Budde
132 views
December 20, 2023
Comments 0
Login to view comments.
Click here to Login